New needle test may predict who needs repeat variceal banding
NCT ID NCT05597488
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a new EUS-guided pressure measurement (EUS-PPGM) can predict how well varices respond to endoscopic banding in people with cirrhosis. Researchers will measure portal pressure in 160 patients and follow them for one year to see if higher pressure at 3 months links to needing more banding. The goal is to improve treatment planning, not to offer a new therapy.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a better way to predict which patients need repeat variceal banding, potentially improving treatment timing and reducing complications.
- What could go wrong
- This is an early-stage observational study, not a treatment trial. The pressure measurement is still experimental, and it may not reliably predict outcomes in all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS PORTAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chinese University of Hong Kong
RECRUITINGHong Kong, Hong Kong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A painless spleen scan could spot deadly vein bleeding risk without endoscopy
- New acid blocker may beat standard drug for Post-Banding ulcers in cirrhosis
- New stent technique could reduce deadly rebleeding in liver cirrhosis
- Ultrasound may replace scopes for bleeding risk in liver patients
- New study aims to stop deadly bleeding in liver patients
- New Ultrasound-Guided scope may slash deadly bleeding risk in liver cancer patients